Basant Maheshwari has recommended a 'bulletproof portfolio' of fail-safe blue-chip stocks which is expected...
Granules India
Vijay Kedia, Basant Maheshwari and Sandip Sabharwal are amongst 10 leading experts who have...
A stock on which Basant Maheshwari was “super, super bullish” has lost his confidence...
Raamdeo Agrawal, who has amassed a net worth of Rs. 1300 crore, has not...
While novice investors turn a deaf ear to Rakesh Jhunjhunwala’s gospels, Porinju Veliyath pays...
Pharma stocks are presently in the doldrums owing to various factors. However, this is...
Raamdeo Agrawal and his ace team at Motilal Oswal never disappoint novice investors. In...
Basant Maheshwari has homed in on a top-quality micro-cap which has all the qualities...
Raamdeo Agrawal, the boss man of Motilal Oswal, recommended a stock on the basis...
Emkay has claimed that a mid-cap Pharma stock, which is already certified as a...
